For lung cancer, a panel consisting of SOX2OT, ANRIL, CEA, CYFRA21-1, and SCCA was reported for NSCLC diagnosis, while SOX2OT and ANRIL were described as biomarkers for NSCLC prognosis [19]. This evidence concerns the gene CDKN2B-AS1 and non-small cell lung carcinoma.